维普期刊资源整合服务平台（V6.5）

45篇 您的检索式：作者名="Forlenza OV"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	Neurostructural predictors of Alzheimer's disease: a META-analysis of VBM studies显示文摘	Ferreira LK Diniz BS Forlenza OV	2011	Neurobiol Aging2011，32，10：	1
2	Inhibition of phospho- lipase A2 reduces neurite outgrowth and neuronalviability显示文摘	Forlenza OV Mendes CT Marie SK	2007	Prostaglandins Leukot Essent Fatty Acids2007，76，1：	1
3	Do CSF total tau, phosphorylated tau, and beta-amyloid 42 help to predict progression of mild cognitive impairment to Alzheimer' s disease ? A systematic review and meta-a- nalysis of the literature 显示文摘	Diniz BS Pinto JJ Forlenza OV	2008	World J Biol Psychiatry2008，9，3：	1
4	Diagnostic transitions in mild cognitive impairment subtypes显示文摘	Forlenza OV Diniz BS Nunes PV	2009	Int Psychogeriatr2009，21，：	1
5	Neurostruc- rural predictors of Alzheimer's disease: a meta-analysis of VBM studies显示文摘	Ferreira LK Diniz BS Forlenza OV	2011	Neurobiol Aging2011，32，10：	1
6	Disease -modifying properties of long - term lithium treatment for anmestic mild cognitive impairment: randomised controlled trial 显示文摘	Forlenza OV Diniz BS Radanovic M	2011	Br J Psychiatry2011，198，5：	1
7	Do CSF total tau, phosphorylated tau, and beta - amyloid 42 help top redict progression of mild cognitive impairment to Alzheimerps disease? A systematic review and meta - analysis of the literature显示文摘	DinizBS Pinto JA J r Forlenza OV	2008	World J Biol Psychiatry2008，9，3：	1
8	Disease-modifying proper- ties of long-term lithium treatment for amnestic mild cognitive im- paimlent :randomised controlled trial 显示文摘	Forlenza OV Diniz BS Anovic M	2011	Br J Psychiatry2011，198，5：	1
9	Phospholipase A2 activation as a therapeutic approach for cognitive enhancement in early-stage Alzheimer disease显示文摘	Schaeffer EL Forlenza OV Gattaz WF	2009	Psychopharmacology (Bed)2009，202，13：	1
10	Do CSF total tau,phosphorylated tau,and beta-amyloid 42 help to predict progression of mild cognitive impairment to Alzheimer' s disease? A systematic review and meta-analysis of the literature显示文摘	Diniz BS Pinto Junior JA Forlenza OV		0，，03：	1
11	Diagnosis and biomarkers of predementia in Alzheimer’s disease显示文摘	Forlenza OV Diniz BS Gattaz WF	2010	BMC Med2010，8，1：	1
12	Disease-modifying properties of long-term lithiumtreatment for amnestic mild cognitive impairment:randomised controlled trial显示文摘	Forlenza OV Diniz BS Radanovic M	2011	Br J Psychiatry2011，198，：	1
13	Effect of brain-derived neurotrophie factor Va166Met polymorphism and serum levels on the progression of mild cognitive impairment显示文摘	Forlenza OV Diniz BS Teixeira AL	2010	World J Biol Psychiatry2010，11，：	1
14	Muscarinic ago-nists reduce tau phosphorylation in non-neuronal cells via GSK 3βinhibition and in neurons显示文摘	Spink JM Dayanandan R	2000	J Neural Transm2000，107，10：	1
15	Do CSF total tau, phosphorylated tau, and beta-amyloid 42 help to predict progression of mild cognitive impairment to Alzheimer's disease? A systematic review and meta-analysis of the literature显示文摘	Diniz BS Pinto Jflnior JA Forlenza OV	2008	World J Biol Psychiatry2008，9，3：	1
16	Neurostructural predictors of Alzheimer's disease:a meta-analysis of VBM studies显示文摘	Fer reira LK Diniz BS Forlenza OV		0，，：	1
17	Neurostructural predictors of Alzheimer's disease: a meta-analysis of VBM stud- ies显示文摘	Ferreira LK Diniz BS Forlenza OV	2011	Neurobiol Aging2011，32，10：	1
18	Long-term sertraline treatment increases expression and decreases phosphorylation of glycogen synthase kinase-3B in platelets of patients with late-life major depression 显示文摘	Joaquim HPG Talib LL Forlenza OV	2012	Journal of Psychiatric Research2012，46，8：	1
19	Does lithium prevent Alzheimer's disease 显示文摘	Forlenza OV de Paula V J Machado-Vieira R	2012	Drugs Aging2012，29，5：	1
20	Diagnostic transitions in mild cognitive impairment subtypes显示文摘	Forlenza OV Diniz BS Nunes PV	2009	Int Psychogeriatr2009，1，6：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示